US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ceribell

14.85

+0.35502.45%

Post-market: 14.850.00000.00%19:32 EDT

Volume:621.58K

Turnover:9.28M

Market Cap:532.47M

PE:-4.39

High:15.18

Open:14.38

Low:14.30

Close:14.49

Loading ...

Overview Company News Filings

Ceribell price target raised to $31 from $30 at Canaccord

Ceribell, Inc. Reports Strong Q3 2024 Growth

Ceribell reports Q3 EPS ($1.85), consensus (34c)

CeriBell Q3 EPS $(1.85) Down From $(1.32) YoY, Sales $17.20M Up From $11.61M YoY

Ceribell Inc Q3 Shr View $-0.34, REV View $17.0 Mln -- Lseg Ibes Data

THOMSON REUTERS

Ceribell Inc: Qtrly Total Revenue of $17.2 Mln

THOMSON REUTERS

Ceribell Inc: Outlook FY24 Total REV $64.2 Mln to $64.7 Mln

THOMSON REUTERS

Ceribell Inc FY2024 REV View $63.9 Mln -- Lseg Ibes Data

THOMSON REUTERS

Ceribell Inc: Qtrly Shr Loss $1.85

THOMSON REUTERS

Ceribell Reports Third Quarter 2024 Financial Results

Ceribell, Inc. Receives Buy Rating Amid Promising Market Penetration in VA Hospitals

CeriBell Receives Authorization from Department of Veterans Affairs for EEG Technology

MT Newswires Live

Ceribell receives authority to operate from Department of Veterans Affairs

Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs

Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Ceribell initiated with a Buy at BofA on ‘differentiated AI algorithm’

Ceribell Inc : Canaccord Genuity Initiates Coverage With Buy Rating; Target Price $30

THOMSON REUTERS

BofA Securities Initiates CeriBell With Buy Rating, $32 Price Target

MT Newswires Live

Ceribell Inc : Bofa Global Research Initiates Coverage With Buy Rating; Price Objective $32

THOMSON REUTERS

Canaccord Genuity Initiates CeriBell at Buy With $30 Price Target

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CBLL/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CBLL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBLL\",,,,,undefined,":{"symbol":"CBLL","market":"US","secType":"STK","nameCN":"Ceribell","latestPrice":14.845,"timestamp":1744920000000,"preClose":14.49,"halted":0,"volume":621579,"hourTrading":{"tag":"盘后","latestPrice":14.845,"preClose":14.845,"latestTime":"19:32 EDT","volume":6609,"amount":98110.6,"timestamp":1744932730916},"delay":0,"floatShares":21912409,"shares":35868339,"eps":-3.385363,"marketStatus":"Market Closed","change":0.355,"latestTime":"04-17 16:00:00 EDT","open":14.38,"high":15.18,"low":14.3,"amount":9280758.75426,"amplitude":0.060732,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.385363,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"listingDate":1728619200000,"exchange":"NASDAQ","adjPreClose":14.49,"preHourTrading":{"tag":"盘前","latestPrice":15.19,"preClose":14.49,"latestTime":"08:23 EDT","volume":66,"amount":993.39999,"timestamp":1744892622477},"postHourTrading":{"tag":"盘后","latestPrice":14.845,"preClose":14.845,"latestTime":"19:32 EDT","volume":6609,"amount":98110.6,"timestamp":1744932730916},"volumeRatio":0.6620269234660353,"impliedVol":0.9753,"impliedVolPercentile":0.8649},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBLL\",,,,,undefined,":{"symbol":"CBLL","floatShares":21912409,"roa":"-17.46%","roe":"-35.75%","lyrEps":-3.385363,"volumeRatio":0.6620269234660353,"shares":35868339,"dividePrice":0,"high":15.18,"amplitude":0.060732,"preClose":14.49,"low":14.3,"week52Low":10.01,"pbRate":"2.79","psRate":"8.14","week52High":32.7489,"institutionHeld":0,"latestPrice":14.845,"eps":-3.385363,"divideRate":0,"volume":621579,"delay":0,"ttmEps":-3.385363,"open":14.38,"prevYearClose":25.88,"prevWeekClose":15,"prevMonthClose":19.21,"prevQuarterClose":19.21,"fiveDayClose":11.15,"twentyDayClose":20.27,"sixtyDayClose":23.24},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CBLL\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2483619002","title":"Ceribell price target raised to $31 from $30 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2483619002","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483619002?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:57","pubTimestamp":1731502620,"startTime":"0","endTime":"0","summary":"Canaccord raised the firm’s price target on Ceribell (CBLL) to $31 from $30 and keeps a Buy rating on the shares. The firm said its first conferenc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ceribell-price-target-raised-to-31-from-30-at-canaccord?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ceribell-price-target-raised-to-31-from-30-at-canaccord?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL"],"gpt_icon":0},{"id":"2483043317","title":"Ceribell, Inc. Reports Strong Q3 2024 Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2483043317","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483043317?lang=en_us&edition=fundamental","pubTime":"2024-11-13 12:55","pubTimestamp":1731473733,"startTime":"0","endTime":"0","summary":"Ceribell, Inc. ( ($CBLL) ) has released its Q3 earnings. Here is a breakdown of the information Ceribell, Inc. presented to its investors. Ceribell...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ceribell-inc-reports-strong-q3-2024-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ceribell-inc-reports-strong-q3-2024-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2483063233","title":"Ceribell reports Q3 EPS ($1.85), consensus (34c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483063233","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483063233?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:55","pubTimestamp":1731448520,"startTime":"0","endTime":"0","summary":"Reports Q3 revenue $17.2M, consensus $16.95M. “I am encouraged by our third quarter results, which reflect our sustained commercial momentum as we ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ceribell-reports-q3-eps-1-85-consensus-34c?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ceribell-reports-q3-eps-1-85-consensus-34c?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL"],"gpt_icon":0},{"id":"2483705718","title":"CeriBell Q3 EPS $(1.85) Down From $(1.32) YoY, Sales $17.20M Up From $11.61M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2483705718","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483705718?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:20","pubTimestamp":1731446452,"startTime":"0","endTime":"0","summary":"CeriBell (NASDAQ:CBLL) reported quarterly losses of $(1.85) per share. This is a 40.15 percent decrease over losses of $(1.32) per share from the same period last year.  The company reported $17.20 million in sales this","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41919766/ceribell-q3-eps-1-85-down-from-1-32-yoy-sales-17-20m-up-from-11-61m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CeriBell Q3 EPS $(1.85) Down From $(1.32) YoY, Sales $17.20M Up From $11.61M YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL"],"gpt_icon":0},{"id":"2483806351","title":"Ceribell Inc  Q3 Shr View $-0.34, REV View $17.0 Mln -- Lseg Ibes Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2483806351","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483806351?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:05","pubTimestamp":1731445506,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nTUA7FXJBX:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2483635870","title":"Ceribell Inc: Qtrly Total Revenue of $17.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2483635870","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483635870?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:05","pubTimestamp":1731445506,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nTUA7FXJBX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2483635160","title":"Ceribell Inc: Outlook FY24 Total REV $64.2 Mln to $64.7 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2483635160","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483635160?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:05","pubTimestamp":1731445506,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nTUA7FXJBX:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2483063515","title":"Ceribell Inc  FY2024 REV View $63.9 Mln -- Lseg Ibes Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2483063515","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483063515?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:05","pubTimestamp":1731445506,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nTUA7FXJBX:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2483063513","title":"Ceribell Inc: Qtrly Shr Loss $1.85","url":"https://stock-news.laohu8.com/highlight/detail?id=2483063513","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483063513?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:05","pubTimestamp":1731445506,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nTUA7FXJBX:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2483105710","title":"Ceribell Reports Third Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2483105710","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483105710?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:05","pubTimestamp":1731445500,"startTime":"0","endTime":"0","summary":"SUNNYVALE, Calif., Nov. 12, 2024  -- CeriBell, Inc.  , a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financial results for the quarter ended September 30, 2024.Reported total revenue of $17.2 million in the third quarter of 2024, a 48% increase compared to the same period in 2023. Achieved gross margin of 87% compared to 84% for the same period in 2023. Completed initial public offering, raising approximately $188 million in net proceeds to the company. Net loss in the third quarter of 2024 was $10.4 millio","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/owBpMuCLkG74Puwq39jMLQ--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/3df5abec81163aa009b2a6a108dd1339","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/owBpMuCLkG74Puwq39jMLQ--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/3df5abec81163aa009b2a6a108dd1339"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ceribell-reports-third-quarter-2024-210500209.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","CBLL","ATO","BK4585","BK4197","BK4588"],"gpt_icon":0},{"id":"2482750014","title":"Ceribell, Inc. Receives Buy Rating Amid Promising Market Penetration in VA Hospitals","url":"https://stock-news.laohu8.com/highlight/detail?id=2482750014","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482750014?lang=en_us&edition=fundamental","pubTime":"2024-11-12 04:25","pubTimestamp":1731356757,"startTime":"0","endTime":"0","summary":"Josh Jennings, an analyst from TD Cowen, maintained the Buy rating on Ceribell, Inc. (CBLL – Research Report). The associated price target remains ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ceribell-inc-receives-buy-rating-amid-promising-market-penetration-in-va-hospitals?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ceribell-inc-receives-buy-rating-amid-promising-market-penetration-in-va-hospitals?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL"],"gpt_icon":0},{"id":"2482787885","title":"CeriBell Receives Authorization from Department of Veterans Affairs for EEG Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2482787885","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482787885?lang=en_us&edition=fundamental","pubTime":"2024-11-11 22:11","pubTimestamp":1731334312,"startTime":"0","endTime":"0","summary":"CeriBell (CBLL) said Monday it received an authority to operate from the Department of Veterans Affairs, allowing the full deployment of the company's point-of-care electroencephalogram, or EEG, techn","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2482789150","title":"Ceribell receives authority to operate from Department of Veterans Affairs","url":"https://stock-news.laohu8.com/highlight/detail?id=2482789150","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482789150?lang=en_us&edition=fundamental","pubTime":"2024-11-11 21:15","pubTimestamp":1731330935,"startTime":"0","endTime":"0","summary":"CeriBell (CBLL) announced the receipt of an Authority to Operate from the Department of Veterans Affairs. The ATO is a significant milestone in ach...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ceribell-receives-authority-to-operate-from-department-of-veterans-affairs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ceribell-receives-authority-to-operate-from-department-of-veterans-affairs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2482786032","title":"Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs","url":"https://stock-news.laohu8.com/highlight/detail?id=2482786032","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482786032?lang=en_us&edition=fundamental","pubTime":"2024-11-11 21:00","pubTimestamp":1731330000,"startTime":"0","endTime":"0","summary":"—Ceribell System stands to reduce costly ICU admissions and intra-facility patient transfers—。—Military veterans face elevated risks of developing seizure disorders—。While Ceribell has been used in certain VA facilities since 2018, this ATO allows Ceribell to leverage VA Wi-Fi networks, enabling remote access to EEG reports and sharing of EEG data between VA locations. Broader use of Ceribell’s features will enable VA hospitals to more efficiently manage neurological emergencies by supporting timely interventions and improved patient outcomes.1-3 The Ceribell System has the potential to provide continuity of care and reduce costs by helping to avoid the transfer of patients to other facilities.4. “Our veterans deserve access to the best care and the most cutting-edge technology possible,\" said Jane Chao, Ph.D., co-founder and chief executive officer of Ceribell. \"In addition to bringingCeribell’s game-changing rapid detection and continuous monitoring capabilities to one of the largest","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/owBpMuCLkG74Puwq39jMLQ--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/3df5abec81163aa009b2a6a108dd1339","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/owBpMuCLkG74Puwq39jMLQ--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/3df5abec81163aa009b2a6a108dd1339"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ceribell-receives-authority-operate-u-130000768.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999001440.SGD","BK4585","CMS","ATO","NTAP","BK4170","LU2346227817.USD","LU1894683348.USD","BK4208","BK4588","LU2637428348.USD","CBLL","BK4082","BK4197","LU1894683264.USD"],"gpt_icon":0},{"id":"2481157781","title":"Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2481157781","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481157781?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:05","pubTimestamp":1731013500,"startTime":"0","endTime":"0","summary":"SUNNYVALE, Calif., Nov.  07, 2024  (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with se","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/07/2977118/0/en/Ceribell-to-Participate-in-the-Canaccord-Genuity-MedTech-Diagnostics-and-Digital-Health-Services-Forum.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4179","CBLL","FET"],"gpt_icon":0},{"id":"2481658670","title":"Ceribell initiated with a Buy at BofA on ‘differentiated AI algorithm’","url":"https://stock-news.laohu8.com/highlight/detail?id=2481658670","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481658670?lang=en_us&edition=fundamental","pubTime":"2024-11-06 19:31","pubTimestamp":1730892670,"startTime":"0","endTime":"0","summary":"As previously reported, BofA analyst Travis Steed initiated coverage of Ceribell  with a Buy rating and $32 price target The company has a first-mover advantage with its rapid point of care EEG, powered by a differentiated AI algorithm, says the analyst, who notes that the $2B total addressable market in the U.S. is only about 3% penetrated today and that utilization in each hospital where the company’s system is deployed can keep moving higher.Ceribell initiated with an Outperform at William Blair","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/c8pJ6Hc13EFaByQh6DEJ0A--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/0176eac0ccabb4c894de3218c38cf5eb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/c8pJ6Hc13EFaByQh6DEJ0A--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/0176eac0ccabb4c894de3218c38cf5eb"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/ceribell-initiated-buy-bofa-differentiated-113110089.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ceribell-initiated-buy-bofa-differentiated-113110089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2481957685","title":"Ceribell Inc : Canaccord Genuity Initiates Coverage With Buy Rating; Target Price $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2481957685","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481957685?lang=en_us&edition=fundamental","pubTime":"2024-11-05 23:10","pubTimestamp":1730819417,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241105:nFWN3MC1YS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2481468375","title":"BofA Securities Initiates CeriBell With Buy Rating, $32 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2481468375","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481468375?lang=en_us&edition=fundamental","pubTime":"2024-11-05 23:01","pubTimestamp":1730818902,"startTime":"0","endTime":"0","summary":"Price: 26.50, Change: +0.26, Percent Change: +0.99","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CBLL"],"gpt_icon":0},{"id":"2481500346","title":"Ceribell Inc : Bofa Global Research Initiates Coverage With Buy Rating; Price Objective $32","url":"https://stock-news.laohu8.com/highlight/detail?id=2481500346","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481500346?lang=en_us&edition=fundamental","pubTime":"2024-11-05 22:33","pubTimestamp":1730817237,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241105:nFWN3MC1V8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2481501584","title":"Canaccord Genuity Initiates CeriBell at Buy With $30 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2481501584","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481501584?lang=en_us&edition=fundamental","pubTime":"2024-11-05 21:30","pubTimestamp":1730813454,"startTime":"0","endTime":"0","summary":"Canaccord Genuity Initiates CeriBell at Buy With $30 Price Target","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CBLL"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":72,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CBLL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-25","symbol":"CBLL","fiscalQuarterEnding":"2024/12","expectedEps":-0.32,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2024-11-12","symbol":"CBLL","fiscalQuarterEnding":"2024/09","expectedEps":-0.82,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-1.85}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CBLL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CBLL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":6,"updateTime":1743825600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CBLL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CBLL","date":"2025-04-17","current":-12.847169,"percent":0.992188,"low":-31.439367,"twenty":-28.370492,"median":-23.028668,"eighty":-18.81521,"high":-9.885848,"avg":-23.337204,"sd":4.716425,"marketCap":519732232},"quantilePoints":[{"date":"2024-10-11","current":-17.636997,"twenty":-17.222009,"median":-16.599526,"eighty":-15.977044,"marketCap":578317118},{"date":"2024-10-18","current":-27.492965,"twenty":-27.233597,"median":-26.455495,"eighty":-19.29695,"marketCap":901494331},{"date":"2024-10-25","current":-28.702676,"twenty":-28.6853,"median":-27.456654,"eighty":-26.040507,"marketCap":941160750},{"date":"2024-10-31","current":-28.246561,"twenty":-28.615797,"median":-28.219411,"eighty":-26.455495,"marketCap":926204733},{"date":"2024-11-08","current":-31.439367,"twenty":-28.963313,"median":-28.463759,"eighty":-26.486619,"marketCap":1030896848},{"date":"2024-11-15","current":-27.13588,"twenty":-29.27825,"median":-28.458329,"eighty":-27.13588,"marketCap":981043460},{"date":"2024-11-22","current":-25.000572,"twenty":-28.963313,"median":-28.246561,"eighty":-25.93676,"marketCap":903845676},{"date":"2024-11-29","current":-28.528199,"twenty":-28.754803,"median":-28.246561,"eighty":-26.043953,"marketCap":1031379984},{"date":"2024-12-06","current":-28.022837,"twenty":-28.754803,"median":-28.33145,"eighty":-26.11912,"marketCap":1013109620},{"date":"2024-12-13","current":-28.934471,"twenty":-29.290749,"median":-28.463759,"eighty":-26.390638,"marketCap":1046067924},{"date":"2024-12-20","current":-26.486932,"twenty":-29.217263,"median":-28.434619,"eighty":-26.480394,"marketCap":957582042},{"date":"2024-12-27","current":-26.239205,"twenty":-29.058794,"median":-28.293244,"eighty":-26.474169,"marketCap":948625981},{"date":"2025-01-03","current":-25.624843,"twenty":-28.959703,"median":-28.107549,"eighty":-26.162518,"marketCap":926414949},{"date":"2025-01-10","current":-22.810668,"twenty":-28.950325,"median":-27.629083,"eighty":-25.703081,"marketCap":824674096},{"date":"2025-01-17","current":-19.966767,"twenty":-28.888112,"median":-27.428293,"eighty":-25.067954,"marketCap":721858516},{"date":"2025-01-24","current":-22.860214,"twenty":-28.702676,"median":-27.180566,"eighty":-24.06912,"marketCap":826465309},{"date":"2025-01-31","current":-23.583576,"twenty":-28.691816,"median":-26.734658,"eighty":-23.038577,"marketCap":852617007},{"date":"2025-02-07","current":-22.404397,"twenty":-28.676835,"median":-26.675204,"eighty":-22.810668,"marketCap":809986156},{"date":"2025-02-14","current":-21.700853,"twenty":-28.676835,"median":-26.471057,"eighty":-22.741305,"marketCap":784550943},{"date":"2025-02-21","current":-22.89985,"twenty":-28.628005,"median":-26.224342,"eighty":-22.412324,"marketCap":827898278},{"date":"2025-02-28","current":-21.066166,"twenty":-28.554982,"median":-26.070751,"eighty":-22.392506,"marketCap":852231734},{"date":"2025-03-07","current":-19.700766,"twenty":-28.530515,"median":-25.634752,"eighty":-21.924596,"marketCap":796994492},{"date":"2025-03-14","current":-18.973735,"twenty":-28.528199,"median":-25.33748,"eighty":-21.562126,"marketCap":767582454},{"date":"2025-03-21","current":-17.971851,"twenty":-28.50271,"median":-25.099663,"eighty":-21.066166,"marketCap":727051231},{"date":"2025-03-28","current":-17.581737,"twenty":-28.470275,"median":-24.772663,"eighty":-20.685126,"marketCap":711269162},{"date":"2025-04-04","current":-16.606451,"twenty":-28.455071,"median":-23.826348,"eighty":-20.087337,"marketCap":671813989},{"date":"2025-04-11","current":-9.885848,"twenty":-28.423651,"median":-23.117849,"eighty":-19.576639,"marketCap":399931979},{"date":"2025-04-17","current":-12.847169,"twenty":-28.370492,"median":-23.028668,"eighty":-18.81521,"marketCap":519732232}],"updateTime":1745071777895}}}